首页> 外文期刊>Surgical infections >Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance
【24h】

Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance

机译:在创伤重症监护评分系统中使用增强的肾脏清除功能以改善有增加的肾脏清除风险的创伤患者的万古霉素剂量

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The Augmented Renal Clearance in Trauma Intensive Care (ARCTIC) scoring system is a validated system to predict augmented renal clearance in trauma patients. This study examined the ability of the ARCTIC score to identify patients at risk for subtherapeutic vancomycin trough concentrations relative to estimated creatinine clearance (eCrCl) alone.Methods: Trauma patients admitted to the intensive care unit from September 2012 to December 2017 who received vancomycin and had a vancomycin trough concentration recorded were included. Patients were excluded if their serum creatinine concentration was >1.3 mg/dL, if they had received vancomycin doses <30 mg/kg per day, an improperly timed trough concentration measurement, or renal replacement therapy. The primary endpoint was an initial subtherapeutic vancomycin trough concentration ( 105 mL/min and ARCTIC score ≥7, eCrCl >105 mL/min and ARCTIC score 105 mL/min and pelvic fracture as risk factors for subtherapeutic trough values. The final model included the addition of ARCTIC score ≥7, which improved the model significantly (p = 0.009). Predictors of subtherapeutic trough concentrations were (odds ratio [95% confidence interval]): eCrCl >105 mL/min (6.5 [1.66–25.07]), ARCTIC score ≥7 (3.26 [1.31–8.09]), and pelvic fracture (4.36 [1.27–14.93]).Conclusion: The ARCTIC score is useful when applied in conjunction with eCrCl. Patients with a eCrCl >105 mL/min and an ARCTIC score ≥7 may require a more aggressive dosing strategy.
机译:背景:创伤性加护病房中增加的肾清除率(ARCTIC)评分系统是一种经过验证的系统,可预测创伤患者的肾脏清除率增加。这项研究检验了ARCTIC评分识别相对于估计的肌酐清除率(eCrCl)仅处于亚治疗性万古霉素谷浓度风险中的患者的能力。方法:2012年9月至2017年12月入住重症监护病房并接受万古霉素治疗并已包括记录的万古霉素谷浓度。如果患者的血清肌酐浓度>1.3μg/ dL,每天接受万古霉素剂量<30μmg/ kg,不适当的定时谷浓度测量或肾脏替代治疗,则排除患者。主要终点为初始治疗药物万古霉素谷浓度(105 mL / min,ARCTIC得分≥7,eCrCl>105μmL/ min,ARCTIC得分105 mL / min,骨盆骨折是治疗子谷值的危险因素。增加ARCTIC得分≥7,可显着改善模型(p = 0.009);治疗亚谷浓度的预测指标为(奇数比[95%置信区间]):eCrCl> 105 mL / min(6.5 [1.66–25.07]), ARCTIC评分≥7(3.26 [1.31-8.09]),骨盆骨折(4.36 [1.27-14.93])。结论:与eCrCl联合使用时,ARCTIC评分是有用的。eCrCl> 105> mL / min且ARCTIC得分≥7可能需要更积极的剂量策略。

著录项

  • 来源
    《Surgical infections》 |2020年第1期|43-47|共5页
  • 作者

  • 作者单位

    Department of Pharmacy Scripps Mercy Hospital|Department of Pharmacy HonorHealth John C. Lincoln Medical Center|Department of Pharmacy Practice Midwestern University College of Pharmacy–Glendale;

    Department of Pharmacy HonorHealth John C. Lincoln Medical Center;

    Department of Pharmacy Practice Midwestern University College of Pharmacy–Glendale;

    Trauma Services and Acute Care Surgery HonorHealth John C. Lincoln Medical Center;

  • 收录信息 美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    augmented renal clearance; therapeutic drug monitoring; trauma critical care; vancomycin;

    机译:肾脏清除率增加;治疗药物监测;创伤重症监护;万古霉素;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号